Exabis Library
Welcome to the e-CCO Library!
DOP31: Development and validation of the IBD-REFER criteria: when should a general practitioner or paediatrician refer a patient for suspected IBD?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP31: Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP31: Gut metabolomic and compositional signatures predict response to treatment with exclusive enteral nutrition in children with active Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP31: Management and outcome of postoperative Crohn’s Disease in the elderly as compared to young adults: Data from Eneida registry
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP32 Clinical and molecular characterisation of patients with durable response to ustekinumab induction therapy: Results from the UNIFI phase 3 studies in moderate-to-severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP32: Biologic treatment does not reduce the risk of postoperative peristomal pyoderma gangrenosum in Crohn’s Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP32: Crohn's disease stricture matrisome analysis reveals the anti-fibrotic activity of milk-fat globule-epidermal growth factor 8 (MFGE8)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP32: Long-term outcomes of enterocutaneous fistula complicating Crohn’s Disease: The ECUFIT study from GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP32: Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP33 Stratification of patients for treatment with adalimumab by a combination of immune-profiling and in vivo efficacy studies in a novel mouse model of ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP33: Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease : a multi-centre Belgian cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP33: Predictors of ileo-rectal anastomosis, permanent ileostomy and recurrence of disease after total colectomy for Crohn’s Colitis: Results over 20 years
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP33: Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence model
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn's disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP34 Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP34: Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP34: Disease activity patterns during the first 5 years after diagnosis in children with ulcerative colitis: a population-based study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP34: Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP35 Monitoring of mucosal T cells subsets under biotherapies in IBD: responders exhibit a phenotype similar to healthy controls
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM